10-K/A XBRL

FORM 10-K/A

Company: NRX Pharmaceuticals, Inc.
Filed: May 26, 2023
Period of Report: December 31, 2022
Accession Number: 0001104659-23-065542

View Document ↗ View on SEC.gov ↗